We apply human iPSC expertise and commercial cell manufacturing experience to cell therapy by designing and delivering iPSC solutions to your requirements. Our offerings include comprehensive services for basic research, proof of concept studies, process development and large-scale custom manufacturing of a range of cell types.

Assessment of drug efficacy and safety is challenging without a predictive model and assays. We provide hiPSC-based solutions for cardiovascular and neural drug screening by combining our demonstrated expertise in iPSC manufacturing and model generation to offer you predictive and translational assays at any throughput.

Ncardia develops and delivers state-of-the-art integrated cardiovascular services to enhance the assessment of cardiac safety and toxicity of drug candidates. Our services are based on fully functional and validated hiPSC-derived cell models that are manufactured in under strict quality assurance guided by an ISO 9001 framework.